Results 221 to 230 of about 2,570,930 (351)

Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study.

open access: yesAmerican Society of Nephrology. Clinical Journal, 2011
L. Rostaing   +11 more
semanticscholar   +1 more source

Response of an Infant With Presumed Multiple Acyl‐CoA Dehydrogenase Deficiency (MADD) to Ketone Supplementation

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Multiple Acyl‐CoA Dehydrogenase Deficiency (MADD) is an autosomal recessive inborn error of metabolism caused by biallelic pathogenic variants in one of three known genes: ETFA, ETFB, and ETFDH. It can cause multisystem dysfunction, including cardiomyopathy in severe cases.
Yutaka Furuta   +17 more
wiley   +1 more source

Sleep disorders in renal patients: a comparative analysis of dialysis and post-renal transplant outcomes. [PDF]

open access: yesSci Rep
Alharbi T   +9 more
europepmc   +1 more source

Distribution and transfer of cyclosporine among the various human lipoprotein classes [PDF]

open access: yes, 1983
Graf, A.   +7 more
core   +1 more source

Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome.

open access: yesAmerican Society of Nephrology. Clinical Journal, 2011
C. Nester   +8 more
semanticscholar   +1 more source

Impact of deceased donor acute kidney injury (AKI) on renal transplant outcomes. [PDF]

open access: yesSurg Open Sci
Nozdrin M   +6 more
europepmc   +1 more source

Aortic Stiffness and Central Wave Reflections Predict Outcome in Renal Transplant Recipients

open access: yesHYPERTENSION, 2011
F. Verbeke   +7 more
semanticscholar   +1 more source

Adverse Prognostic Impact of Pretransplant Serum Ferritin and Hepcidin on Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation

open access: yes
American Journal of Hematology, EarlyView.
Michelle Pirotte   +6 more
wiley   +1 more source

Cancer therapy‐induced ototoxicity: Current challenges and emerging management strategies

open access: yesAnimal Models and Experimental Medicine, EarlyView.
This review comprehensively examines the key risk factors for cancer therapy‐induced ototoxicity, including cumulative drug dose, genetic susceptibility, and combined treatment regimens. It highlights current challenges in ototoxicity monitoring, such as insufficient timeliness and limited clinical adoption, and advocates for standardized auditory ...
Yuqi Huang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy